David Michael Lutz Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 343 N Wallace Wilkinson Blvd, Liberty, KY 42539 Phone: 606-787-5574 Fax: 606-787-5604 |
Mr. Douglas Todd Downing, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 397 N Wallace Wilkinson Blvd, Liberty, KY 42539 Phone: 606-787-1976 |
Jennifer Shugars Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1457 S Wallace Wilkinson Blvd, Liberty, KY 42539 Phone: 606-677-0596 Fax: 606-677-0297 |
Brooke Sprowles, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 343 N Wallace Wilkinson Blvd, Liberty, KY 42539 Phone: 606-787-5574 Fax: 606-787-5604 |
Phyllis Reynolds Spurlin, R,PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 671 Wolford Ave, Liberty, KY 42539 Phone: 606-787-4236 |
Dr. Tonya G Moses, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 343 N Wallace Wilkinson Blvd, Liberty, KY 42539 Phone: 606-787-5574 |
News Archive
A new machine learning platform can identify patients with colorectal cancer and helps predict their disease severity and survival, according to a study involving samples from thousands of subjects.
While debate about recreational marijuana use continues, researchers are investigating the effectiveness of cannabis for treating pain, spasticity, and a host of other medical problems. In a symposium organized by the McGill University Health Centre as part of the 2015 American Association for the Advancement of Science Annual Meeting held this week in San Jose, California, world-renowned experts from North America and the U.K. share their perspectives on the therapeutic potential of medical cannabis and explore the emerging science behind it.
Exercise may reduce, and even reverse, bone loss caused by hormone and radiation therapies used in the treatment of localized prostate cancer, thereby decreasing the potential risk of bone fractures and improving quality of life for these men, according to a study presented on October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
At the 23rd ECNP Congress 2010 in Amsterdam, Professor Dr. Jim van Os, Chairman of the Department of Psychiatry and Neuropsychology at Maastricht University Medical Centre, The Netherlands, will present the EU-GEI project, involving more than 7,500 patients and their families, which brings together a multidisciplinary research team from 15 countries in the largest effort to date to find gene-environment interactions underlying schizophrenia risk.
A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.
› Verified 7 days ago